Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma - Wick, Antje; Desjardins, Annick; Suárez García, Cristina; Forsyth, Peter; Gueorguieva, Ivelina; Burkholder, Tiana; Cleverly, Ann Louise; Estrem, Shawn T.; Wang, Shuaicheng; Lahn, Michael M.; Guba, Susan C.; Capper, David; et al. (Investigational new drugs, 2020)
Gesehen am 18.11.2021